Indiatimes

VisionGATE is proud to announce All India Rank 1 for GATE Exams with their student, Jayadeep More

MUMBAI, India, March 17, 2023 /PRNewswire/ -- GATE Results were announced on 16th March, 2023 and Mr Jayadeep More a student of VisionGATE from Mumbai has achieved a remarkable feat by securing the ...
EurekAlert!

Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum

Sydney, Australia and Phoenix, AZ, USA – October 28, 2013 – VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical ...
Fierce Healthcare

VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT 3D Imaging System for Early Diagnosis of Cancer

PHOENIX, Jan. 6, 2012 /PRNewswire via COMTEX/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported ...
FierceBiotech

3-D cell imaging outfit VisionGate eyes $75M IPO

Arizona's VisionGate is gearing up for an IPO, making plans to go public to spur development of its 3-D cell microscope technology for early lung cancer detection. As The Phoenix Business Journal ...
FierceBiotech

—Full Automation is Major Advance Enabling Wide Use of Cell-CT 3D Imaging System in Routine Clinical Practice—

PHOENIX, Jan. 6, 2012 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has ...
GEN

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

Trials will test LuCED test either alone or in combination with x-ray CT in primary screening and to monitor lung cancer patients post surgery. VisionGate announced a collaboration with the Sheba ...
EDN

VisionGate selects MathStar to help deliver Cell-CT cellular characterization platform

The folks at VisionGate, a privately held corporation in Washington State, have developed a novel 3D cellular characterization platform, the Cell-CT, based on the company's broadly patented technology ...
AZ Central

Anatomy of a med-tech startup: VisionGate

Description: A non-invasive test for lung cancer in which patient sputum samples are processed on a system that computes 3-D images of the cells. About: Alan Nelson, a physicist by training, had ...
The Business Journals

VisionGate raises $20M to target early stage lung cancer

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. VisionGate will accelerate clinical trial programs for its ...
Business Insider

VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services, Biopharmaceutical Services and Cancer Prevention Medicines

SEATTLE, WA, April 05, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce today the advancement of its breakthrough ...
The Business Journals

VisionGate automates 3D cell microscope

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. VisionGate Inc., which has a <a href="http://www ...
Security

VisionGate Selects MathStar to Help Deliver Innovative Cell-CT(TM) Cellular Characterization Platform

Dr. Alan Nelson , VisionGate's chairman and CEO, said, "MathStar's FPOA architecture provides the performance and flexibility to implement the computationally demanding filtering and backprojection ...